Stock comparison
RESMED INC is 1.1x more valuable than DEXCOM INC by market capitalization ($30.24 B vs $28.18 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
RMD is larger
RESMED INC is 1.1x more valuable than DEXCOM INC by market capitalization ($30.24 B vs $28.18 B).
Market value leader
RMD
RESMED INC is 1.1x more valuable than DEXCOM INC by market capitalization ($30.24 B vs $28.18 B).
Revenue leader
RMD
RMD: $5.15B vs DXCM: $4.66B.
Profit leader
RMD
RMD: $1.40B vs DXCM: $836.30M.
Margin leader
RMD
RMD: 27.2% vs DXCM: 17.9% net margin.
| Metric | RMD | DXCM |
|---|---|---|
| Market cap | $30.24 B | $28.18 B |
| US-listed rank | #464 | #493 |
| Revenue (latest FY) | $5.15B | $4.66B |
| Net income (latest FY) | $1.40B | $836.30M |
| Net margin | 27.2% | 17.9% |
| P/E (trailing FY) | 21.6x | 33.7x |
| SEC filings | 2,518 | 2,566 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
RESMED INC is 1.1x more valuable than DEXCOM INC by market capitalization ($30.24 B vs $28.18 B).
In their latest fiscal years, RESMED INC reported $5.15B in revenue while DEXCOM INC reported $4.66B.
Full pages: RESMED INC and DEXCOM INC, or browse the full rankings.